tada - I disagree with your anaysis that this was done to just keep each other company operating. They were just business moves to not infringe on each others properties as they are different legal entities with not exactly the same shareholders now. If you read the original agreement that goes back to 2005, they ended up with some overlapping areas as the two comapnies were splitting. RVX had some patents that RVX Therapeutics might infringe on with their development and some possible ApoA-1 development might have infringed on RVX Therapeutics areas. One came up first so Therapeutics paid for a license there and later, the earlier agreement was restricting RVX so they paid Zenith to remove that. These monies were paid for rights, etc., not loaned or the RVX return would have also been $2.5 million, not $1.05 million. No skullduggery here, just business. Do you really think Ken Dart would have been okay with what you posit when he owns way more of Zenith than RVX? If he was okay with it, he would have lent the money to each directly where he could control the terms and receive proper return for his actions. he has done that before when he backed the Citi loan.